Products & Services · Other revenues

Product and Service, Other — Other revenues

Viatris Product and Service, Other — Other revenues decreased by 41.1% to $7.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 34.2%, from $11.10M to $7.30M. Over 2 years (FY 2021 to FY 2023), Product and Service, Other — Other revenues shows a downward trend with a -27.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ1 2026

How to read this metric

An increase suggests successful monetization of secondary assets or expanded service offerings, while a decrease may indicate a decline in non-core business activities or a strategic shift toward primary product focus.

Detailed definition

This metric represents revenue streams generated by a business segment that fall outside of its primary core product or...

Peer comparison

Similar to 'Other Revenue' or 'Ancillary Income' reported by other large-cap pharmaceutical and generic drug manufacturers, often representing a small but stable percentage of total top-line results.

Metric ID: vtrs_segment_product_and_service_other_other_revenues

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$16.10M$16.10M$10.30M$13.50M$11.40M$10.80M$8.90M$10.00M$9.10M$8.00M$11.40M$9.90M$10.70M$13.20M$11.10M$13.10M$12.40M$7.30M
QoQ Change+0.0%-36.0%+31.1%-15.6%-5.3%-17.6%+12.4%-9.0%-12.1%+42.5%-13.2%+8.1%+23.4%-15.9%+18.0%-5.3%-41.1%
YoY Change-29.2%-32.9%-13.6%-25.9%-20.2%-25.9%+28.1%-1.0%+17.6%+65.0%+12.1%+22.4%-6.1%-34.2%
Range$7.30M$16.10M
CAGR-17.0%
Avg YoY Growth-3.1%
Median YoY Growth-9.8%
Current Streak2 quarters decline

Frequently Asked Questions

What is Viatris's product and service, other — other revenues?
Viatris (VTRS) reported product and service, other — other revenues of $7.30M in Q1 2026.
How has Viatris's product and service, other — other revenues changed year-over-year?
Viatris's product and service, other — other revenues decreased by 34.2% year-over-year, from $11.10M to $7.30M.
What is the long-term trend for Viatris's product and service, other — other revenues?
Over 2 years (2021 to 2023), Viatris's product and service, other — other revenues has grown at a -27.2% compound annual growth rate (CAGR), from $72.70M to $38.50M.
What does product and service, other — other revenues mean?
Revenue earned from secondary business activities or services that are not part of the company's core pharmaceutical product lines.